AGLYX Performance — Ariel Global Fund, Institutional Class
Data updated: 2026-08-20
AGLYX returned +24.90% year to date and +35.05% over one year to Jun 2026. Annualised returns are +20.11% over 3 years and +12.46% over 5 years. The fund beat its Global Large Blend category average: $100 invested three years ago grew to $173, against $156 for the category, and to $135 over one year, against $118. Volatility over the past three years was 15.00% a year. In the 12 months to Jun 2026 the fund took in a net $5.9M, and assets reached $68.67M.
AGLYX Growth of $100
What $100 invested in Ariel Global Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Large Blend category average over the same months.
| Period | AGLYX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $135 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $173 | $156 |
| 5 years (Jul 2021 – Jun 2026) | $180 | $149 |
| Since data start (Jul 2019 – Jun 2026) | $226 | $204 |
AGLYX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +24.90% |
| 1 year | +35.05% |
| 3 years (annualised) | +20.11% |
| 5 years (annualised) | +12.46% |
AGLYX Annual Returns
Calendar-year total returns of Ariel Global Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +24.90% |
| 2025 | +23.59% |
| 2024 | +7.41% |
| 2023 | +12.67% |
| 2022 | −5.24% |
| 2021 | +11.75% |
| 2020 | +8.05% |
| 2019 (Jul–Dec) | +5.53% |
AGLYX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.5% | +3.1% | −7.6% | +14.5% | +11.1% | +0.6% | — | — | — | — | — | — |
| 2025 | +5.7% | +2.2% | −1.6% | −0.7% | +3.5% | +4.6% | −1.3% | +3.1% | +3.2% | +3.6% | −2.0% | +1.5% |
| 2024 | −0.5% | +2.8% | +5.0% | −4.5% | +2.7% | −1.1% | +3.0% | +0.3% | +3.6% | −4.3% | +2.5% | −1.7% |
| 2023 | +3.6% | −2.1% | +2.8% | +1.5% | −2.1% | +4.1% | +1.6% | −2.3% | −2.4% | −4.2% | +8.6% | +3.6% |
| 2022 | +1.0% | −2.6% | +1.8% | −3.4% | +2.5% | −4.3% | +0.4% | −3.4% | −7.2% | +6.0% | +7.0% | −2.1% |
| 2021 | +0.9% | +1.8% | +0.7% | +1.7% | +2.5% | +1.9% | −1.4% | +2.0% | −4.4% | +3.6% | −2.5% | +4.6% |
| 2020 | −0.5% | −5.9% | −7.3% | +8.6% | +1.0% | +1.9% | +0.7% | +4.0% | −3.2% | −3.6% | +7.1% | +6.4% |
| 2019 | — | — | — | — | — | — | −1.5% | −2.0% | +2.8% | +0.9% | +1.9% | +3.4% |
AGLYX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.00%
- 3-year Sharpe ratio: 1.04 (vs 4.5% risk-free rate)
- Best month: +14.49% (Apr 2026)
- Worst month: −7.64% (Mar 2026)
AGLYX Fund Flows
Monthly money in and out of Ariel Global Fund, from SEC Form N-PORT.
- 12-month net flow: $5.9M
- 12-month gross sales (incl. reinvestments): $12.7M
- Sales ÷ redemptions: 1.88×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $957K | $1.2M | −$233K |
| May 2026 | $247K | $909K | −$662K |
| Apr 2026 | $1.6M | $322K | $1.2M |
| Mar 2026 | $162K | $451K | −$290K |
| Feb 2026 | $199K | $330K | −$132K |
| Jan 2026 | $284K | $296K | −$12K |
| Dec 2025 | $8.0M | $790K | $7.2M |
| Nov 2025 | $423K | $718K | −$295K |
| Oct 2025 | $290K | $232K | $58K |
| Sep 2025 | $370K | $640K | −$270K |
| Aug 2025 | $107K | $356K | −$249K |
| Jul 2025 | $73K | $515K | −$442K |
AGLYX Assets Under Management
Net assets of Ariel Global Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $68.67M |
| 2026-03-31 | $53.13M |
| 2025-12-31 | $54.87M |
| 2025-09-30 | $54.37M |
| 2025-06-30 | $52.72M |
| 2025-03-31 | $50.04M |
| 2024-12-31 | $47.37M |
| 2024-09-30 | $57.55M |
| 2024-06-28 | $54.83M |
| 2024-03-28 | $62.62M |
| 2023-12-29 | $66.92M |
| 2023-09-29 | $90.77M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.